5[1]Akio K,Hisakazu Y,Ryoichi O,et al.Antibacterial activity of β-lactam antibiotics against extended-spectrum β-lactamase producing bacteria[J].Jpn J Antibiot,1999,52(9): 585-594.
6[2]National Committee for Clinical Laboratory Standards.MIC testing supplement tables[S].M100-S13(M7).NCCLS,2003.
7[3]Wang H,Dzink-Fox JL,Chen MJ,et al.Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations[J].Antimicrob Agents Chemother,2001,45(5): 1515-1521.
8[4]Wang H,Kelkar S,Wu WY,et al.Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China[J].Antimicrob Agents Chemother,2003,47(2): 790-793.
9Kania I,Gospodark E,Ulatowska B.Analysis of the bacterial strains isolated from urinary samples of hospitalized and ambulatory patients[J].Med Sci Monit,2000,6(3):1122-1127.
10Farrell DJ,Morrissey I,De Rubeis D,et al.A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection[J].J Infect,2003,46(2):94-100.
